Lonza | chemanager-online.com - Chemistry and Life Science

May. 12, 2020
News & Opinions
Pfizer to Make Space for Vaccine Production
To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to be shared out with a network of 200 contractors in the US and Europe.
May. 04, 2020
News & Opinions
Lonza Teams up with Moderna on Covid-19 Vaccine
Swiss fine chemicals producer and CDMO Lonza has signed a 10-year worldwide strategic collaboration agreement with Cambridge, Massachusetts-based US biotech Moderna to enable larger scale manufacture of Moderna’s RNA-1273 based ...
Apr. 20, 2020
Topics
Agrochemical and Custom Manufacturing Industry: Connected Fates
The fate of the agrochemical innovation, development, product launch and production are strongly linked to the parallel development of the fine chemicals and custom manufacturing industry. Starting Point
Feb. 20, 2020
Topics
Chemspec Europe Returns to Cologne
Chemspec Europe, the International Exhibition for Fine and Specialty Chemicals, returns to Cologne for its 35th edition. From November 11 – 12, 2020, manufacturers, suppliers and distributors of fine and specialty chemicals present ...
Jan. 28, 2020
News & Opinions
Lonza's next CEO to Come from Pharma or Biotech
Lonza’s search for a new CEO is under way but the Swiss-based fine chemicals producer and CDMO’s supervisory board has warned that finding the right leader could take longer than the last CEO stayed in office. ...
Dec. 09, 2019
Topics
Innovative Chemistry Between Mountains and Lakes
Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan, as well as EU facilities in the United Kingdom and Germany. But do not ...
Dec. 06, 2019
Topics
Made in Switzerland – Exported Worldwide
The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70,000 employees and are thus the undisputed ...
Nov. 13, 2019
News & Opinions
Lonza CEO Marc Funk Quits Unexpectedly
Marc Funk resigned as CEO of Lonza on Nov. 12, citing personal reasons, after only eight months at the helm of the Swiss CDMO. The news took most observers and investors by surprise, and the company’s share price gave up 4.5%.
Sep. 11, 2019
Topics
The Pharma CDMO Challenge
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manufacturing to contract development and manufacturing ...
Sep. 11, 2019
Topics
Experts Statements: Christian Dowdeswell, Lonza
The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manufacturing to contract development and manufacturing ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag